Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 5,379 | 4,534 | 4,025 | 4,927 | 5,135 |
| Operating Income | -5,379 | -4,534 | -4,025 | -4,927 | -5,135 |
| Interest Expense | 7 | -2 | 4 | 5 | 2 |
| Other Income | 11 | 9 | 8 | 0 | 0 |
| Pre-tax Income | -5,375 | -4,523 | -4,021 | -4,932 | -5,137 |
| Net Income Continuous | -5,375 | -4,523 | -4,021 | -4,932 | -5,137 |
| Net Income | $-5,375 | $-4,523 | $-4,021 | $-4,932 | $-5,137 |
| EPS Basic Total Ops | -8,812.85 | -32,497.00 | -31,128.45 | -77,731.09 | -106,542.60 |
| EPS Basic Continuous Ops | 27,769.71 | -32,318.61 | -30,944.95 | -77,658.77 | -106,311.30 |
| EPS Diluted Total Ops | -8,812.85 | -32,497.00 | -31,128.45 | -77,731.09 | -106,542.60 |
| EPS Diluted Continuous Ops | 27,494.48 | -32,318.61 | -30,669.71 | -77,658.77 | -106,311.30 |
| EBITDA(a) | $-5,378 | $-4,533 | $-4,024 | $-4,925 | $-5,132 |